228 related articles for article (PubMed ID: 7737689)
1. The bio-logical role of invariant chain (Ii) in MHC class II antigen presentation.
Nordeng TW; Bakke O
Immunol Lett; 1994 Dec; 43(1-2):47-55. PubMed ID: 7737689
[TBL] [Abstract][Full Text] [Related]
2. Endosomal localization of MHC class II-invariant chain complexes.
Miller J
Immunol Res; 1994; 13(4):244-52. PubMed ID: 7616052
[TBL] [Abstract][Full Text] [Related]
3. Efficient internalization of MHC class II-invariant chain complexes is not sufficient for invariant chain proteolysis and class II antigen presentation.
Swier K; Miller J
J Immunol; 1995 Jul; 155(2):630-43. PubMed ID: 7608541
[TBL] [Abstract][Full Text] [Related]
4. MHC class II antigen processing: biology of invariant chain.
Sant AJ; Miller J
Curr Opin Immunol; 1994 Feb; 6(1):57-63. PubMed ID: 8172680
[TBL] [Abstract][Full Text] [Related]
5. Exogenous CLIP localizes into endocytic compartment of cells upon internalization: implications for antigen presentation by MHC class II molecules.
Mukherjee R; Chaturvedi P; Lee-Chan E; Singh B
Mol Immunol; 2008 Apr; 45(8):2166-76. PubMed ID: 18279957
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of the invariant chain by protein kinase C regulates MHC class II trafficking to antigen-processing compartments.
Anderson HA; Bergstralh DT; Kawamura T; Blauvelt A; Roche PA
J Immunol; 1999 Nov; 163(10):5435-43. PubMed ID: 10553069
[TBL] [Abstract][Full Text] [Related]
7. Developing and shedding inhibitions: how MHC class II molecules reach maturity.
Busch R; Mellins ED
Curr Opin Immunol; 1996 Feb; 8(1):51-8. PubMed ID: 8729446
[TBL] [Abstract][Full Text] [Related]
8. Presentation of endogenously synthesized MHC class II-restricted epitopes by MHC class II cancer vaccines is independent of transporter associated with Ag processing and the proteasome.
Dissanayake SK; Tuera N; Ostrand-Rosenberg S
J Immunol; 2005 Feb; 174(4):1811-9. PubMed ID: 15699107
[TBL] [Abstract][Full Text] [Related]
9. Intracellular transport of MHC class II and associated invariant chain in antigen presenting cells from AP-3-deficient mocha mice.
Sevilla LM; Richter SS; Miller J
Cell Immunol; 2001 Jun; 210(2):143-53. PubMed ID: 11520080
[TBL] [Abstract][Full Text] [Related]
10. Polarized transport of MHC class II molecules in Madin-Darby canine kidney cells is directed by a leucine-based signal in the cytoplasmic tail of the beta-chain.
Simonsen A; Pedersen KW; Nordeng TW; von der Lippe A; Stang E; Long EO; Bakke O
J Immunol; 1999 Sep; 163(5):2540-8. PubMed ID: 10452991
[TBL] [Abstract][Full Text] [Related]
11. Actin microfilaments control the MHC class II antigen presentation pathway in B cells.
Barois N; Forquet F; Davoust J
J Cell Sci; 1998 Jul; 111 ( Pt 13)():1791-800. PubMed ID: 9625742
[TBL] [Abstract][Full Text] [Related]
12. Protein sorting within the MHC class II antigen-processing pathway.
Marks MS
Immunol Res; 1998; 17(1-2):141-54. PubMed ID: 9479576
[TBL] [Abstract][Full Text] [Related]
13. Isoforms of the invariant chain regulate transport of MHC class II molecules to antigen processing compartments.
Warmerdam PA; Long EO; Roche PA
J Cell Biol; 1996 Apr; 133(2):281-91. PubMed ID: 8609162
[TBL] [Abstract][Full Text] [Related]
14. Intracellular traffic to compartments for MHC class II peptide loading: signals for endosomal and polarized sorting.
Bakke O; Nordeng TW
Immunol Rev; 1999 Dec; 172():171-87. PubMed ID: 10631946
[TBL] [Abstract][Full Text] [Related]
15. Involvement of clathrin and AP-2 in the trafficking of MHC class II molecules to antigen-processing compartments.
McCormick PJ; Martina JA; Bonifacino JS
Proc Natl Acad Sci U S A; 2005 May; 102(22):7910-5. PubMed ID: 15911768
[TBL] [Abstract][Full Text] [Related]
16. Early endosomes are required for major histocompatiblity complex class II transport to peptide-loading compartments.
Brachet V; Péhau-Arnaudet G; Desaymard C; Raposo G; Amigorena S
Mol Biol Cell; 1999 Sep; 10(9):2891-904. PubMed ID: 10473634
[TBL] [Abstract][Full Text] [Related]
17. Asparagine endopeptidase is not essential for class II MHC antigen presentation but is required for processing of cathepsin L in mice.
Maehr R; Hang HC; Mintern JD; Kim YM; Cuvillier A; Nishimura M; Yamada K; Shirahama-Noda K; Hara-Nishimura I; Ploegh HL
J Immunol; 2005 Jun; 174(11):7066-74. PubMed ID: 15905550
[TBL] [Abstract][Full Text] [Related]
18. Invariant chain peptides enhancing or inhibiting the presentation of antigenic peptides by major histocompatibility complex class II molecules.
Adams S; Humphreys RE
Eur J Immunol; 1995 Jun; 25(6):1693-702. PubMed ID: 7614997
[TBL] [Abstract][Full Text] [Related]
19. Ancient features of the MHC class II presentation pathway, and a model for the possible origin of MHC molecules.
Dijkstra JM; Yamaguchi T
Immunogenetics; 2019 Mar; 71(3):233-249. PubMed ID: 30377750
[TBL] [Abstract][Full Text] [Related]
20. Cathepsins and compartmentalization in antigen presentation.
Riese RJ; Chapman HA
Curr Opin Immunol; 2000 Feb; 12(1):107-13. PubMed ID: 10679409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
